Larvol Delta - Autobahn-Therapeutics-Completes-Dosing-in-its-Phase-1-Multipleascending-Dose-Study-of-ABX002-for-Major-Depressive-Disorder-and-Reports-Company-Progress

ABX-002 - Autobahn Therap

https://www.businesswire.com/news/home/20230911332427/en/Autobahn-Therapeutics-Completes-Dosing-in-its-Phase-1-Multiple-ascending-Dose-Study-of-ABX-002-for-Major-Depressive-Disorder-and-Reports-Company-Progress

Sep 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next